Episode

CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients

Podcast
Hematologic Oncology Update
Published
Dec 11, 2025
Duration seconds
3510
Processing state
not_requested
Canonical source
https://hematologic-oncology.captivate.fm/episode/5559-patientproject2025-cartclinicians
Audio
https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/f4aefd1c-ff3d-43a0-a133-7d2501c8dd40.mp3
JSON
/v1/public/podcasts/hematologic-oncology-update-916423/episodes/car-t-cell-therapy-for-non-hodgkin-lymphoma-cancer-q-a-discussing-common-questions-posed-by-patients
Markdown
/podcast/hematologic-oncology-update-916423/car-t-cell-therapy-for-non-hodgkin-lymphoma-cancer-q-a-discussing-common-questions-posed-by-patients.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/car-t-cell-therapy-for-non-hodgkin-lymphoma-cancer-q-a-discussing-common-questions-posed-by-patients/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/hematologic-oncology-update-916423/car-t-cell-therapy-for-non-hodgkin-lymphoma-cancer-q-a-discussing-common-questions-posed-by-patients.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Jeremy S Abramson from Massachusetts General Hospital in Boston and Dr Loretta J Nastoupil from CommonSpirit Mercy Hospital in Durango, Colorado, discuss the clinical applications of chimeric antigen receptor T-cell therapy for patients with non-Hodgkin lymphoma.    CME information and select publications here .